Google
Apple
English (UK)
English (India)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
KENVUE INC. |
Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 20.61 USD | -0.96% | -0.39% | 0.00% | |
Financials (USD)
| Sales 2023 * | 15.57B | Sales 2024 * | 15.94B | Capitalization | 39.47B |
|---|---|---|---|---|---|
| Net income 2023 * | 1.79B | Net income 2024 * | 2.1B | EV / Sales 2023 * | 3,00x |
| Net Debt 2023 * | 7.23B | Net Debt 2024 * | 6.84B | EV / Sales 2024 * | 2,90x |
| P/E ratio 2023 * | 20,7x | P/E ratio 2024 * | 18,7x | Employees | 22,200 |
| Yield 2023 * | 1,98% | Yield 2024 * | 3,91% | Free-Float | 90.48% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.96% | ||
| 1 week | -0.39% | ||
| Current month | +0.83% | ||
| 1 month | +7.57% | ||
| 3 months | -3.24% | ||
| 6 months | -17.92% |
1 week
19.22
21.39
1 month
19.0021.39
Current year
17.8227.80
1 year
17.8227.80
3 years
17.8227.80
5 years
17.8227.80
10 years
17.8227.80
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.76% | 505 M€ | -10.01% | ||
| 2.00% | 475 M€ | -4.19% | - | |
| 1.93% | 2 M€ | +14.14% | - | |
| 1.65% | 1,293 M€ | -6.70% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-12-08 | 20.61 | -0.96% | 24,535,970 |
| 23-12-07 | 20.81 | +7.32% | 60,070,763 |
| 23-12-06 | 19.39 | -3.87% | 37,456,398 |
| 23-12-05 | 20.17 | -2.18% | 19,199,057 |
| 23-12-04 | 20.62 | -0.34% | 22,516,193 |
Delayed Quote Nyse, December 08, 2023 at 04:00 pm EST
More quotes
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. The business is organized around 3 product families:
- health products: for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.);
- body care products: hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.);
- other: notably oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.).
Product marketing is assured through direct sales, distributors and the Internet.
Sector
Personal Products
Calendar
2024-07-17
- Q2 2024 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
20.61USD
Average target price
23.96USD
Spread / Average Target
+16.26%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 39 468 M $ | |
| -4.23% | 342 B $ | |
| -9.46% | 119 B $ | |
| -1.50% | 70 995 M $ | |
| -2.06% | 63 540 M $ | |
| -46.10% | 47 855 M $ | |
| +23.60% | 32 312 M $ | |
| -3.66% | 17 643 M $ | |
| +16.88% | 12 522 M $ | |
| -2.48% | 11 627 M $ |
